By analyzing RNA-sequencing data based on TCGA, Xiao et al. [31] showed NCAPG to be over-expressed in 93% of tumor samples from lung squamous cell carcinoma, 74% for hepatocellular carcinoma, and 69% for breast cancer. This evidence concerns the gene NCAPG and hepatocellular carcinoma.